sisomicin has been researched along with cefotaxime in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Suzuki, Y; Yokota, N | 1 |
| Firsov, AA | 2 |
| Clavijo, E; García Luque, IG; Nogales, MC; Perea, EJ | 1 |
| Inamori, Y; Kato, Y; Kubo, M | 1 |
| Linda, H; Patzer, J | 1 |
| Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
| Orefici, G; Scopetti, F | 1 |
| Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
| Accornero, L; Bacigalupo, A; Carella, AM; Congiu, AM; Costa, G; Occhini, D; Santini, G; Sbaffi, A; Sciutto, C; Van Lint, MT | 1 |
| Deguchi, K; Furukawa, T; Hyodo, A; Miyake, Y; Uji, T | 1 |
13 other study(ies) available for sisomicin and cefotaxime
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
[Synergistic action of cefodizime with other antimicrobial agents on clinically isolated microorganisms. II. Synergistic action with sisomicin].
Topics: Cefotaxime; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Sisomicin | 1992 |
In vitro simulated pharmacokinetics profiles: forecasting antibiotic optimal dosage.
Topics: Anti-Bacterial Agents; Cefotaxime; Escherichia coli; Half-Life; Humans; Infusions, Intravenous; Kidney Diseases; Models, Biological; Sisomicin | 1991 |
[Correlation of dose-antimicrobial effect in modeling in vitro pharmacokinetic profiles of normal and impaired elimination of antibiotics].
Topics: Cefotaxime; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Metabolic Clearance Rate; Sisomicin | 1989 |
Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin | 1988 |
[Studies on the combination action of sisomicin, gentamicin and cefmenoxime, ceftizoxime, cefoperazone, cefotetan against Serratia marcescens and Pseudomonas aeruginosa].
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefotetan; Ceftizoxime; Cephamycins; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1985 |
[Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
Topics: Amikacin; Cefotaxime; Drug Synergism; Enterococcus faecalis; Gentamicins; In Vitro Techniques; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin | 1984 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
Susceptibility of Mycobacterium fortuitum to antibacterial agents as evaluated by disk diffusion and agar dilution methods.
Topics: Antibiotics, Antitubercular; Cefotaxime; Diffusion; Erythromycin; Indicator Dilution Techniques; Microbial Sensitivity Tests; Mycobacterium; Sisomicin | 1983 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
Cefoperazone versus cefotaxime, plus amikacin or sisomicin, in fever and infection in hematologic granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anemia, Aplastic; Cefoperazone; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Immunosuppression Therapy; Infections; Kanamycin; Leukemia; Male; Middle Aged; Random Allocation; Sisomicin | 1984 |
[Therapeutic efficacy of cefodizime in combination with aminoglycosides against systemic infections caused by Pseudomonas aeruginosa in immunocompromised tumour bearing mice].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Immunocompromised Host; Male; Mice; Mice, Inbred Strains; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Sisomicin | 1993 |